REPORTS of experimental tumors resistant to various nucleic acid, amino acid, and folic acid antagonists used in cancer chemotherapy are now fairly numerous (Welch, 1959) 
investigated, and sublines resistant to TEM were developed by consecutive passages of tumor cells in animals given intraperitoneal injections of this drug.
MATERIALS AND METHODS
Mice.-Female white Swiss mice, 20-25 g., were obtained from A. R. Schmidt & Co., Madison, Wisconsin, and were watered and fed Rockland rat diet ad libitum.
Unless otherwise noted, there were 10 mice of comparable weight in each experimental group. Survival times were recorded to the nearest half day.
Transplanatation of tumors.-Ascites tumor cells were transplanted by withdrawing the ascites fluid from a donor mouse bearing a 7-day tumor growth. The fluid was centrifuged for 5 minutes in a clinical centrifuge at 1470 x g, the supernate was decanted, and the cells were diluted 1:20 with isotonic saline. Each animal received 0-2 ml. of the cell suspension(107 cells).
17.jection of drUg8.-Drugs were injected intraperitoneally beginning 24 hours after tumor implantation, and continued at 24-hour intervals when 3 or 4 injections were given or at a 48-hour interval when 2 injections were given. Drug dosages of TEM designated A-F in the Tables are as follows 11-9 ± 1-Ot (7-5-15-5)t 2-7 ± 0-23t (1-3-4-O)l Tables I and 11 shows that mice bearing the resistant sublines had longer survival times. The experiment with the Ehrlich resistant subline was run at the same time as that with the Ehrlich sensitive line in Table 1 , and average survival times were 16-6 (resistant) and 11-9 (sensitive) days. Control groups of the 8180 sensitive line and Treatment D subline were run at the same time as the experiment with the S180 Treatment A subline shown in Table 11 , with the following survival times and packed cell volumes: sensitive, 12-1 ± 1-2 days and 2-4 ± 0-29 ml. ; Treatment D subline, 14-8 ± 0-9 days and -2-2 ± 0-25 ml. Since packed cell volumes at death did not differ greatly, the resistant tumors evidently grow more slowly than the sensitive lines.
Treatment B prolonged the average survival times of mice bearing the sensitive tumors (Table 1 ), but not of those bearing the resistant sublines (Table 11 ). Treatment C prolonged the average survival times of mice bearing the resistant S 1 80 sublines 7 but the average packed cell volumes measured at death were much greater than that of the sensitive line given Treatment C. The data in Table III  TABLE III To determine if the resistance was stable in the absence of TEM, a series was started from the 27th transplant generation of the S180 Treatment A subline and carried without the drug. Tests of the 8th transplant generation (Table IV) that the tumor was still resistant, with both the slower growth characteristic and the proliferation in the presence of TEM shown by the treated resistant subline. Effect of antimetabolites on S180 cell populations sensitive and resistant to TEM Table V § Group contained 9 mice. 1 1 The first figure in brackets is the number of n-jice without ascites cells or solid tumors; the second figure is the number with no ascites ceRs or fluid but with one solid tumor in the peritoneal cavity.
6 drugs had a greater chemotherapeutic effect on the resistant Treatment A subline, and a number of animals bearing this subline were free of tumor cells when killed on the 56th day. These have been considered as 56-day survivors in the calculation of average survival time. A few animals had no ascites cells or fluid but exhibited a single solid tumor within the peritoneal cavity.
The slower growth of the resistant subline must be considered in evaluating these results, and since both tumor lines were treated with drug 24 hours after transplantation, it might be argued that the resistant tumor was in an earlier stage of growth. However, the relative increase in sensitivity to these antimetabolites displayed by the resistant tumor was not the same for all the drugs. Thioguanine and 6-mereaptopurine were the least effective drugs, and amethopterin and azauridine the most effective, in prolonging survival times of mice bearing the tumor sensitive to TEM. With the tumor resistant to TEM, thiogu'anine was the most effective drug and amethopterin and azauridine were the least effective; 6-mercaptopurine was more effective than the latter two drugs.
DISCUSSION
The only other report of a tumor resistant to TEM of which we are aware is that of Jackson (1954) 
